Related Articles
Combination glecaprevir, pibrentasvir with ezetimibe prevents HCV in transplantation
LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according…
FDA approves Skyrizi for moderately to severely active Crohn’s disease
The FDA has approved AbbVie’s Skyrizi for the treatment of adults with moderately to severely active Crohn’s disease, according to a company press release.Previously approved…
European Commission approves Rinvoq for moderate to severe UC
The European Commission approved Rinvoq for the treatment of patients with moderate to severe ulcerative colitis who had an inadequate response, lost response or were…
FGS Kicks Off Its All-New Webinar Series
This month marks the beginning of a new webinar series initiated and hosted by FGS President, Dr. Alison Schneider. November’s webinar will focus on HPB/Biliary…
2019 FGS Annual Meeting Wrap-Up
September 15, 2019 marked the conclusion of the 54th Florida Gastroenterologic Society’s Annual Meeting. Over 475 Gastroenterologists, Advanced Practice Providers, GI Nurses and Techs converged…